Table 1 Demographic and key characteristics of participants across all cohorts
Characteristics | CU (n = 760) | CI (n = 932) | P-value |
|---|---|---|---|
Age, years mean (s.d.) | 69.6 (7.5) | 72.7 (7.7) | <0.0001 |
Females, n (%) | 465 (61 %) | 387 (42 %) | <0.0001 |
Race | |||
White, n (%) | 700 (92 %) | 883 (95 %) | 0.028 |
Unknown, n (%) | 4 (0.5 %) | 3 (0.3 %) | 0.708 |
Ethnicity | |||
Not Hispanic/Latino, n (%) | 733 (96 %) | 901 (97 %) | 0.790 |
Unknown, n (%) | 4 (0.5 %) | 3 (0.3 %) | 1.000 |
APOEε4 carriers, n (%) | 265 (35 %) | 516 (55 %) | <0.0001 |
Aβ-positive, n (%) | 265 (35 %) | 686 (74 %) | <0.0001 |
HCV, z-score mean (s.d.) | −0.02 (1.0) | −1.3 (1.4) | <0.0001 |
CSF Aβ1-42, z-score mean (s.d.) | −0.52 (1.1) | −1.4 (0.8) | <0.0001 |
CSF NfL, z-score mean (s.d.) | −0.002 (0.6) | 1.3 (2.5) | <0.0001 |
CSF t-tau, z-score mean (s.d.) | 0.15 (1.2) | 1.0 (1.7) | <0.0001 |
CSF Ng, z-score mean (s.d.) | 0.22 (1.2) | 0.95 (1.4) | <0.0001 |
CSF SNAP25, z-score mean (s.d.) | 0.28 (1.3) | 0.91 (1.7) | <0.0001 |